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Abstract
Background: Much is written about cognitive and motor development; less is known about social and emotional
consequences of growing up with congenital hypothyroidism (CH).
The objectives of the study were: (1) to compare health related quality of life (HRQoL) and self-worth of 10 year old
patients with CH with the general population; (2) to explore associations of disease factors, IQ and motor skills with
the outcomes.
Methods: Children with CH and their parents completed several questionnaires. Patients were classified to ‘severe
CH, n = 41’ or ‘moderate/mild CH, n = 41’ based on pre-treatment FT4 concentration.
Differences between CH and the general population were tested by analysis of covariance and one sample t-tests
(mean scale scores HRQoL and self-worth), chi-square tests and binomial tests (% at risk of impaired HRQoL and
self-worth). Linear regression analyses corrected for gender were conducted to explore associations of the
outcomes with disease factors, IQ and motor skills.
Results: Patients with CH reported lower mean HRQoL on motor, cognitive and social functioning, and on
autonomy and positive emotions (p < 0.0001). Patients were also more often at risk for impaired HRQoL and
self-worth. No differences were found between the severity groups. Lower IQ was only significant associated with
worse cognitive HRQoL. Initial FT4 plasma, age at onset of therapy, initial T4 dose and motor skills were not
significantly associated with HRQoL and self-worth.
Conclusions: Negative consequences in terms of HRQoL and self-worth are prevalent in children with CH,
independent of disease factors, IQ and motor skills. Physicians should to be attentive to these consequences and
provide attention and supportive care.
Keywords: Congenital hypothyroidism, Quality of life, Self-worth, Children
Background
Severe intellectual disability associated with congenital
hypothyroidism (CH) is prevented by newborn screen-
ing and early treatment. However, children with CH
still undergo a brief period of thyroid hormone defi-
ciency reflecting etiology of thyroid disease, severity
and treatment factors. Thyroid hormone is essential
for almost all life processes, but most important for
normal development of the central nervous system of
the fetus and the infant. Neonatal screening programmes
for CH have been effective in preventing serious cogni-
tive and motor deficits through early initiation of T4
supplementation [1,2]. However, several studies showed
that children and adults with CH, especially those with
severe CH, still experience a range of cognitive and
motor deficits [3-6].
Clearly, much is written about cognitive and motor de-
velopment of children with CH. There is a growing body
of literature directed at social and emotional conse-
quences of children growing up with CH. Many psycho-
logical studies conclude that children with different
chronic diseases are at higher risk for emotional and
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behavior problems [7,8]. Some studies found behavior
disorders and psychiatric disturbances in children with
CH [8-11]. Other studies were directed at assessing
health related quality of life (HRQoL) in young adults
with CH [12-14]. However, HRQoL and self-worth in
children have not been studied thoroughly. HRQoL can
be used as an indicator of adjustment, which covers the
patient’s perceptions of his or her physical, emotional, so-
cial and cognitive functions, as well as the patient’s per-
ceived health status and well-being [15]. In addition,
positive self-worth is a significant factor influencing over-
all mental health and psychological well-being [16,17],
and is regarded by major theorists as a basic psycho-
logical need [18].
CH is a chronic life-long disease [19], which may affect
the patient’s daily life because of the hospital visits, the
daily T4 administration, the need of regular dose adjust-
ments and sometimes the need of adjuvant medical care
such as speech training and physiotherapy. Besides, CH
could have a negative impact on motor skills and in
some (severely affected) patients also on the cognitive
development [3], which in turn might affect their social
life, self-esteem and emotional functioning.
In order to be able to adequately support the psycho-
motor development of children with CH, insight in their
social-emotional functioning is necessary. Therefore the
purpose of the present study was (1) to assess HRQoL
and self-worth in children with CH at ten years of age
born in 1992–1993 and compare the results to those of
the general (healthy) population, and (2) to explore the
influence of disease factors, IQ and motor skills on
HRQoL and self-worth.
Methods
Screening method and treatment strategy
The Dutch neonatal CH screening method is primarily
based on the measurement of T4 in filter paper blood
spots. In 1992 and 1993 sampling was performed be-
tween 5 and 8 days after birth. T4, expressed as standard
deviation score, is compared to the day mean. If T4
was≤−0.8 SD, thyrotropin (TSH) was additionally measured.
When T4 was≤−3.0 SD or TSH was ≥50 μU/ml children
were referred immediately. Children with a dubious result
(−3.0<T4≤−2.1 SD, or 25≤TSH<50 μU/ml) underwent a
second heelpuncture and were referred if the result was
again dubious, or abnormal. The etiological classification of
CH was based upon initial presentation, thyroid function
determinants and thyroid imaging.
In 1992–93 Dutch pediatricians were advised to start
with T4-supplementation in a dose of 6 to 8 μg/kg.day.
In accordance with international guidelines T4-dose
adjustments were based on thyroid function determi-
nants, obtained at regular outpatient follow-up visits.
Sample
The complete cohort of patients with CH born in The
Netherlands in 1992 and 1993 consisted of 141 patients
(Table 1). Patients were classified as CH-T (CH of thyr-
oidal origin), CH of central origin (CH-C) or CH not yet
specified. CH-T was further classified as CH-T due to
thyroid agenesis, thyroid dysgenesis, or thyroid dyshor-
mogenesis. In this study, only children with CH-T were
included.
From the original cohort 3 patients had died, 4 had
moved abroad and 4 had transient CH. The parents of
the remaining 130 patients were contacted via their
pediatricians, whose responses led to the exclusion of
patients with CH-C (n = 15), with a known or suspected
syndrome (n= 9), with a brain tumour (n = 1), and
patients of whom the mother was treated with T4 during
pregnancy (n = 2). Three patients were excluded because
the recommended dose adjustments were not made in
time due to misunderstandings (Table 1, ‘not suitable’ to
participate). Furthermore, the parents of 18 patients
declined participation (Table 1, ‘not willing’ to partici-
pate). Parents of a total of 82 patients gave their written
informed consent. To ascertain that the participating
patients were well-treated (i.e. TSH 0.4-4.0 μU/ml) at
the time of testing, the most recent measurement of thy-
roid function prior to the psychological tests was evalu-
ated and if necessary T4-dose was adjusted. This resulted
in dose adjustments for 20 patients. Patients were
Table 1 Characteristics of the 1992–1993 cohort of patients with congenital hypothyroidism (CH)
Etiology Total Non-participants Participants
not suitable not willing
CH-T due to thyroid agenesis 24 6 1 17
CH-T due to thyroid dysgenesis 51 2 1 48
CH-T due to thyroid dyshormonogenesis 24 3 4 17
CH-C 16 15 1 0
CH n.o.s. 26 15 11 0
Total CH 141 41 18 82
Four groups are presented; the total group, the group of patients who did not participate divided in patients not suitable or not willing to participate and the
group of patients who did participate. For each group, the subdivision according to etiological classification is given. CH n.o.s., CH not otherwise specified.
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classified to subgroups based on their pre-treatment FT4
concentration: ‘severe CH’: FT4 ≤ 0.3 ng/dL (≤4 pmol/L),
‘moderate/mild CH’: FT4 > 0.3 ng/dL (FT4 > 4.0 pmol/L).
The reference range for FT4 is 0.9-2.2 ng/dL (12–28
pmol/L) for children aged 2–6 weeks.
Procedure
All children and their parents were asked to complete the
questionnaires in the Academic Medical Center (AMC)
(except for 7 patients who were tested in their local hospi-
tals) under the supervision of the same psychologist
(LvdSV), who was blinded for the patients’ medical details.
The assistance of the psychologist was restricted to ex-
plaining the meaning of difficult words. The study proto-
col was approved by the institutional review board of the
Emma Children’s Hospital/Academic Medical Center and
the privacy committee of the Dutch CH Screening Board.
Measures
HRQoL
Health-related quality of life (HRQoL) of the children
with CH was assessed with the TNO-AZL Children’s
Quality of Life questionnaire; Parent Form for children
aged 6 to 11 years (TACQoL-PF) [20] and Child Form
for children aged 8 to 15 years (TACQoL-CF) [21,22].
These questionnaires are originally Dutch instruments
that measure generic HRQoL [20-23]. The question-
naires measure health status problems weighted by the
impact of the health status problems on well-being. It
offers the respondent the possibility of differentiating be-
tween their functioning and the way they feel about it.
The items are clustered into multi-item scales with
higher scores indicating better quality of life. The TAC-
QoL (CF and PF) contains seven scales of eight items
each: physical functioning, autonomy, motor function-
ing, cognitive functioning and school performances, so-
cial functioning, positive emotions and negative
emotions. The Cronbach’s alphas in our study popula-
tion were moderate to good (0.67-0.87) with the excep-
tion of the Autonomy scale of the TACQoL-CF
(Cronbach’s alpha <0.4). Age-matched norm data from
the Dutch general population were available. Children
with a chronic medical condition in this norm population
were excluded. This resulted in a norm population of 449
healthy children. The psychometric properties, validity
and reliability, of the TACQoL are satisfactory [20-23].
Self-worth
The translated version of the The Self-Perception Profile
for Children (CBSK) [24] was used to assess patients’
self-worth. The CBSK, meant for children aged 8–
12 years, consisted of 36 items. Each answer was scored
between 1 (most competent) and 4 (least competent).
Several aspects of self-perception were measured in six
subscales, each consisting of six items: school compe-
tence, social acceptance, athletic competence, physical
appearance, behavioral conduct and global self-worth.
The Cronbach’s alphas of the CBSK scales in our study
population were moderate to good (0.67-0.78). Dutch
norms are based on a representative sample of 361
Dutch children. The psychometric properties and reli-
ability of the CBSK are satisfactory [24].
Intelligence (IQ) and motor skills
Intelligence was measured with the Dutch version of the
Wechsler Intelligence Scale for Children, 3rd Edition,
(WISC-III) [25]. Three intelligence quotients were
derived: Full Scale Intelligence Quotient (FSIQ); Verbal
Intelligence Quotient (VIQ); and Performance Intel-
ligence Quotient (PIQ). In the normative population, each
IQ-score has a mean of 100 (SD 15).
Motor skills were assessed with the Movement Assess-
ment Battery for Children (MABC) [26,27], designed for
identification of impairments of motor function in chil-
dren aged 4–12 years. The test results are expressed in
terms of a total motor impairment score (‘Total MABC
score’); higher scores indicate more motor problems.
For a comprehensive description of these measures we
refer to our study on IQ and motor outcome of ten year
old patients with CH [3].
Statistical analysis
Data were analysed using SPSS version 12.0 (SPSS Inc.,
Chicago, IL). Before conducting the final analyses several
preparation analyses were conducted. Firstly, scale scores
were computed and missing data imputed on the basis
of the guidelines of the TACQoL [17]. In calculation of
the scale scores, one missing combined-item score was
allowed for. The missing score was replaced by the mean
value of the non-missing item scores. Second, the in-
ternal consistencies (Cronbach’s alphas) of the scales
were calculated, and the distributions of the scale scores
were considered.
HRQoL and self-worth of the group with CH were
compared with that of the norm population in two ways:
(1) using mean scale scores, (2) using the percentage of
children at risk of impaired HRQoL and self-worth.
Patients with CH (total group) were compared to the
norm population, and thereafter the severe and moder-
ate/mild subgroups as well. Differences between the se-
vere and moderate/mild subgroups with CH were also
tested. Analyses of covariance (ANCOVA) were con-
ducted to test for differences on the TACQoL mean
scale-scores between the group with CH and norm
population and between the severity groups, corrected
for gender. Because the database of the CBSK norm data
was not available, we used the mean scores that were
presented in the manual of the CBSK. Therefore one
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sample t-tests were performed to test whether the sev-
eral CBSK-scales scores (means) of the children with CH
differed from the means in the norm population [24].
Patients with CH (total group) were compared to the
norm population, and thereafter the severe and moder-
ate/mild subgroups as well. Differences between the se-
verity groups regarding the CBSK-scale scores were
tested with ANCOVA. To adjust for multiple testing, we
used a Bonferroni correction and adjusted the alpha to
0.007 (0.05/7) for the TACQoL and 0.008 (0.05/6) for
the CBSK. Effect sizes (d) were calculated by dividing
the difference in mean score between the patients with
CH (total group) and norm population by the standard
deviation of the scores in the norm population. We con-
sidered effect sizes up to 0.2, 0.5, and 0.8 to be small,
moderate and large respectively [28].
To create a clinically meaningful distinction, children
with CH are categorized into being ‘at risk’ or ‘not at risk’
for problems (i.e. impaired HRQoL, impaired self-worth),
based on percentile norms by age and gender in the
norm population. The value of the 25 th percentile in the
norm population was used for the scales of the TACQoL.
Although there is no gold standard for good or bad
HRQoL yet, this definition is considered to be a suitable
way to differentiate between individuals with higher scale
scores from individuals with lower scale scores [29]. The
percentage at risk in the group with CH was compared
with the percentage in the norm population using Chi-
square tests (χ2-tests, p < 0.007;0.05/7). The definition of
being at risk for impaired self-worth was based on the
value of the 15 th percentile (CBSK scales) in the norm
population as recommended in the manual of the CBSK
[24]. We tested whether the percentage of children with
CH with scores below the value of the 15th percentile in
the norm population was different from 15% using bino-
mial tests (p < 0.008; 0.05/6).
Linear regression analyses were conducted to explore
the influence of disease factors (initial FT4 plasma, age at
onset therapy, initial T4 dose) on HRQoL and self-worth.
Regression models were also fitted for HRQoL and self-
worth predicted by full scale IQ, and predicted by motor
skills (total score). All regression models were corrected
for gender. A significance level of 0.007 (0.05/7) was used
for the HRQoL scales and 0.008 (0.05/6) for the scales of
self-worth. Because of the explorative nature of the re-
gression analyses, regression coefficients at p < 0.05 and
p < 0.01 were also reported, to be considered as a trend.
Results
Sample characteristics
The characteristics of the participating patients with
CH and their parents are given in Table 2. Of the 82
patients with CH (53 girls, 65%), 41 had severe CH
and 41 had moderate/mild CH. The median age at
start of T4 supplementation was 20 days for the total
group. The IQ scores of the participating patients with
CH are given in Table 2. For all details, we refer to a
previous publication [3].
Health related quality of life (HRQoL): mean scores
Child-report
The total group with CH reported significantly worse
HRQoL than the norm population on four out of the
Table 2 Characteristics of participating CH patients and
their parents
PATIENTS Severe CH Moderate/
Mild CH
Number of patients
(male/female)
41 (13/28) 41 (16/25)
Initial FT4
in ng/dl (95%CI)* 0.1 (0.0-0.3) 0.7 (0.3-1.1)
[in nmol/l (95%CI)] [1.8 (0.0-4.0)] [9.4 (4.2-20.2]
Age at start of
T4 supplementation
in mean days (range)
19 (10–43) 25 (2–73)
Mean IQ scores at 10.5 yr ** Severe Moderate Mild
Full scale IQ 93.7
(89.5-97.9)
96.2
(88.9-103.5)
105.0
(99.5-110.4)
Verbal IQ 94.9
(90.1-99.7)
95.4
(87.9-102.9)
103.6
(98.2-109.1)
Performance IQ 93.9
(90.0-97.8)
98.0
(91.1-104.9)
105.3
(99.3-111.3)
Mean motor scores at 10.5 yr **
Total MABC score*** 14.3
(11.8-16.8)
9.7
(6.8-12.5)
11.6
(8.7-14.6)
PARENTS
Number of the
participating parents
(mothers/fathers)
35 (26/9) 38 (33/5)
Parental marital status
Married/living
together, n (%)
32 (91) 37 (97)
Single, n (%) 3 (9) 1 (3)
Educational level father
Low, n (%) 11 (31) 18 (47)
Middle, n (%) 11 (31) 11 (29)
High, n (%) 13 (38) 9 (24)
Educational level father
Low, n (%) 17 (47) 18 (47)
Middle, n (%) 12 (34) 12 (30)
High, n (%) 7 (19) 8 (23)
* Reference range for FT4 in children aged 2–6 wk is 0.9-2.2 ng/dlL (12–28
pmol/l) (34).
** published in Kempers et al. (3).
*** No motor problems: (Total MABC score≤ 9.5), borderline motor problems :
(9.5 < Total MABC score < 13.5, definite motor problems: (Total MABC
score ≥ 13.5).
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seven scales of the TACQoL: motor functioning F
(1,524) = 18.04; cognitive functioning F(1,523) = 20.52;
social functioning, F(1,521) = 13.47; positive emotions F
(1,522) = 16.10. The differences were small to moderate;
effect sizes (d) ranged from 0.3 to 0.6 (Table 3).
HRQoL of the severe group with CH appeared to be
significantly worse than that of the norm population
on four scales: motor functioning F(1,483) = 14.74; auto-
nomy F(1,483) = 11.774; cognitive functioning F
(1,483) = 28.07; social functioning F(1,482) = 16.40, while
the moderate/mild group with CH scored worse than
the norm on motor functioning and positive emotions;
F(1,487) = 6.62 and F(1,486) = 15.589 respectively.
Parent-report
Parents of patients with CH (total group) reported sig-
nificantly worse HRQoL in their children than parents
of the norm population on four out of the seven scales
of the TACQoL: motor functioning F(1,543) = 23.76; cog-
nitive functioning F(1,543) = 38.18; social functioning F
(1,543) = 8.21; negative emotions F(1,543) = 6.77. The dif-
ferences were small to large; effect sizes (d) ranged from
0.4 to 0.8 (Table 3).
HRQoL of the severe group with CH appeared to be
significantly worse (p < 0.007) than that of the norm
population on motor and cognitive functioning; F
(1,502) = 26.61 and F(1,502) = 36.36 respectively. The
moderate/mild group with CH scored only significantly
worse than the norm on cognitive functioning F
(1,503) = 11.61.
Self-worth: mean scores
With respect to the self-worth only one significant dif-
ference was found (Table 4). The girls with CH reported
lower social acceptance than the girls in the norm popu-
lation; T = (1,50) =−2.75, effect sizes (d) = 0.4.
Differences according to CH severity (severe versus mild/
moderate): mean scores HRQoL and Self-worth
There were no significant differences found between
the severity groups for HRQoL and self-worth (Table 3
and 4).
Impaired HRQoL: percentage at risk
Child-report
The total group of patients with CH showed signifi-
cantly higher percentages of children at risk for
Table 3 Health-related quality of life (TACQoL)1: patients with congenital hypothyroidism (CH) versus the norm
population; Mean scores, Standard deviations (SD’s) and effect sizes2
Total CH Severe CH Moderate/Mild CH Norm population Effect size
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Total
Child-report
n= 82 n= 41 n= 41 n= 449
Physical Functioning 23.7 (4.8) 23.3 (4.9) 24.0 (4.6) 25.2 (5.0) 0.3
Motor Functioning 28.3 (3.5) *** 27.9 (3.8) *** 28.7 (3.3) * 29.8 (3.1) 0.5
Autonomy 30.9 (1.5) 30.5 (1.7) ** 31.3 (1.1) 31.5 (1.5) 0.4
Cognitive functioning 26.5 (4.9) *** 25.3 (5.1) *** 27.7 (4.4) 28.7 (3.7) 0.6
Social Functioning 28.6 (4.0) *** 28.0 (4.2) *** 29.1 (3.9) 29.9 (2.5) 0.5
Positive emotions 12.6 (2.6) *** 13.0 (2.4) 12.2 (2.8) *** 13.7 (2.4) 0.5
Negative emotions 12.0 (2.5) 11.4 (2.6) 12.5 (2.3) 11.9 (2.6) 0.0
Parent-report
n= 82 n= 41 n= 41 n= 465
Physical Functioning 26.9 (4.4) 26.5 (4.3) 27.3 (4.3) 27.3 (3.8) 0.1
Motor Functioning 29.3 (2.8) *** 28.7 (3.2) *** 30.0 (2.3) 30.8 (2.3) 0.7
Autonomy 31.2 (1.9) 31.1 (1.9) 31.2 (2.0) 31.6 (1.2) 0.3
Cognitive functioning 26.0 (5.2) *** 25.1 (5.7) *** 26.9 (4.5) ** 29.0 (3.7) 0.8
Social Functioning 29.0 (3.1) ** 28.9 (3.0) 29.1 (3.3) 29.9 (2.5) 0.4
Positive emotions 14.5 (2.1) 14.4 (2.3) 14.7 (2.0) 14.7 (2.0) 0.1
Negative emotions 11.0 (2.4) ** 10.9 (1.8) 11.2 (2.8) 11.8 (2.4) 0.3
1Higher scores represent better HRQoL: range 0 – 32 for physical, motor, autonomy, cognitive, social; range 0 – 16 for positive and negative moods.
2effect size (d): total CH versus norm population.
*p < 0.007: difference between CH patients and norm population according to ANOVA by group and gender.
**p < 0.001: difference between CH patients and norm population according to ANOVA by group and gender.
***p < 0.0001: difference between CH patients and norm population according to ANOVA by group and gender.
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impaired HRQoL (38% to 48%) than the norm popula-
tion on four scales of the TACQoL: motor functioning,
autonomy, cognitive functioning and positive emotions
(Table 5).
In the severe group, significantly more patients with
CH than children in the norm population were consid-
ered at risk for problems with physical, motor and
cognitive functioning, and with autonomy; ranging
from 46% to 57%. Patients in the moderate/mild group
with CH were considered more at risk for problems
with motor functioning (46%) and positive emotions
(47%).
Parent-report
According to the parents, patients with CH (total, severe
and moderate/mild) had a significantly greater risk for
impaired HRQoL than children in the norm population
on two scales of the TACQoL: motor and cognitive func-
tioning: 49% and 61% respectively (Table 5).
Impaired Self-worth: percentage at risk
Patients with CH (total, severe, moderate/mild) showed
higher percentages at risk for impaired self-worth than
the norm population with regard to school competence
and athletic competence; ranging from 27 to 34% versus
15% in the norm group (Table 6).
Asssociations of disease factors, IQ and motor skills with
HRQoL and self-worth
The regression analyses demonstrated only one signifi-
cant result: higher full scale IQ was found to be corre-
lated with better (parent reported) cognitive functioning
(β= 0.38; p = 0.001).
Several trends could be reported, based on signifi-
cance levels of 0.01 and 0.05. Regarding the disease
factors, higher initial T4 dose was associated with
better (parent-reported) physical HRQoL (β= 0.37;
p < 0.05). Furthermore, higher full scale IQ was found
to be correlated with better HRQoL regarding (child
reported) negative emotions (β= 0.28; p < 0.05) and
(parent reported) positive emotions (β= 0.23; p < 0.05).
Finally, better motor skills were associated with
higher (parent reported) HRQoL scores on motor
functioning (β= 0.24; p < 0.05) and autonomy (β= 0.30;
p < 0.01), and with better self-worth; social acceptance
(β= 0.24; p < 0.05) and athletic competence (β= 0.29;
p < 0.05).
Discussion
This is one of the first studies that assessed self-worth
and health related quality of life (HRQoL) using a self-
and proxy report in early treated children with CH.
The results of the study showed that CH could have a
negative impact on several aspects of HRQoL and self-
Table 4 Self-worth (CBSK)1: patients with congenital hypothyroidism (CH) versus the norm population; Mean scores,
Standard deviations (SD’s) and effect sizes2
Total CH Severe CH Moderate/Mild CH Norm group Effect size
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Total
Boys
n= 27 n= 11 n= 16 n= 180
School competence 17.2 (3.2) 16.4 (3.7) 17.7 (2.8) 17.4 (3.5) 0.1
Social acceptance 18.6 (3.8) 17.8 (4.7) 19.2 (3.0) 17.8 (3.8) 0.2
Athletic competence 17.6 (3.8) 16.6 (4.4) 18.3 (3.2) 18.7 (3.3) 0.3
Physical appearance 20.0 (2.9) 19.4 (3.0) 20.4 (2.9) 20.1 (3.6) 0.0
Behavioral conduct 17.6 (3.1) 17.6 (3.3) 17.6 (2.6) 17.0 (2.8) 0.2
General self-worth 20.0 (2.7) 19.9 (3.1) 20.0 (2.5) 20.0 (3.0) 0.0
Girls
n= 51 n= 26 n= 25 n= 181
School competence 15.4 (3.6) 15.8 (3.4) 14.9 (3.8) 16.3 (3.4) 0.3
Social acceptance 15.9 (4.0) * 16.2 (4.0) 15.7 (3.3) 17.5 (3.7) 0.4
Athletic competence 16.1 (3.9) 17.0 (4.1) 16.5 (3.7) 17.6 (3.8) 0.4
Physical appearance 18.5 (4.2) 18.6 (4.5) 18.4 (4.0) 18.9 (4.0) 0.1
Behavioral conduct 17.0 (3.5) 17.5 (3.3) 16.5 (3.3) 18.0 (3.4) 0.3
General self-worth 19.1 (2.6) 19.5 (3.7) 18.6 (3.0) 19.4 (3.5) 0.1
1Higher scores represent better self-worth: range 6 – 24 for all scales.
2effect size (d): total CH versus norm population.
* p < 0.007: difference between CH patients and norm population according to one-sample t-test.
van der Sluijs Veer et al. Child and Adolescent Psychiatry and Mental Health 2012, 6:32 Page 6 of 10
http://www.capmh.com/content/6/1/32
worth. Ten year old children with CH born in 1992–
1993 experienced worse HRQoL than the norm popu-
lation with respect to cognitive -, motor- and social
functioning, positive emotions, negative emotions and
autonomy. In addition, a greater percentage of children
with CH, especially patients with severe CH, appeared
to be at risk for impaired HRQoL as well as for
impaired self-worth with respect to school performance
and athletic performance.
These results are in line with our previous results
among young adults with CH, who reported also lower
HRQoL and lower self-worth than healthy peers [12].
Two other studies evaluated the HRQoL in young adults
with CH [13,14]. Sato et al. showed that the HRQoL of
young adults did not differ from healthy controls [13]. In
a recent study of Leger et al. [14], young adults with CH
had a lower HRQoL than their healthy peers, as in our
study. These authors underlined the need of early and
consequent monitoring patients with CH [14]. Several
other studies showed that children and adolescents with
CH were at risk of social-emotional problems, such as
behavioral disorders and psychiatric disturbances. Tinelli
et al. [30] found that adolescents (> 12 years) scored sig-
nificantly higher than controls on withdrawal, anxiety/
depression, thought problems, attention problems and
aggressive behavior. Bisacchi et al. [14] found more
Table 6 Percentage at risk for impaired Self-worth (CBSK): patients with congenital hypothyroidism (CH) versus the
norm population
Total CH Severe CH Moderate/Mild CH Norm group
n=82 n=41 n=41 n=361
School competence 30% * 32% * 27%* 15%
Social acceptance 24% 24% 24% 15%
Athletic competence 33% * 32% * 34% * 15%
Physical appearance 15% 14% 17% 15%
Behavioral conduct 26% 22% 29% 15%
General self-worth 19% 22% 17% 15%
*p < 0.008: difference between CH patients and norm population according to binominal test.
Table 5 Percentage at risk for impaired health related quality of life (TACQoL): patients with congenital
hypothyroidism (CH) versus the norm population
Total CH Severe CH Moderate/Mild CH Norm population
Child-report
n= 82 n= 41 n= 41 n= 449
Physical Functioning 40% 46% * 34% 25%
Motor Functioning 48% ** 50% * 46% * 25%
Autonomy 38% ** 46% ** 29% 25%
Cognitive functioning 40% * 57% ** 25% 25%
Social Functioning 34% 41% 28% 25%
Positive emotions 45% * 42% 47% * 25%
Negative emotions 30% 36% 25% 25%
Parent-report
n= 82 n= 41 n= 41 n= 465
Physical Functioning 34% 37% 32% 25%
Motor Functioning 55% ** 61% ** 49%* 25%
Autonomy 27% 32% 22% 25%
Cognitive functioning 56% ** 61% ** 51%* 25%
Social Functioning 29% 34% 24% 25%
Positive emotions 34% 37% 25% 25%
Negative emotions 38% 39% 37% 25%
1 25 th Percentiles of norm population are not exact 25% due to distribution of scale scores; percentiles approach 25th, ranging from 17th – 31st percentile.
*p < 0.007: difference between CH patients and norm population according to Chi-square test **p < 0.0001: difference between CH patients and norm population
according to Chi-square test.
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internalizing and externalizing problems in 6–10 years
patients with CH. However, they found no differences
between patients and controls in other age groups. The
results of our study can be considered in line with a
growing body of literature about the psychological and
social consequences of medical treatment in children
with chronic diseases. Many of these studies concluded
that children with a chronic disease show more mal-
adjustment than healthy children [7,8,31].
The most persuasive result is that patients with CH
reported considerably worse parent- and child-reported
HRQoL in the domains “motor functioning” and “cogni-
tive functioning”, also presented in a high percentage of
patients considered at risk for impaired HRQoL in these
domains. In addition, children with CH appeared to be
more at risk for low self-worth in school competence
and athletic competence. We also found that lower IQ
was associated with lower scores on cognitive function-
ing and that worse motor skills tended to be associated
with worse self-worth regarding athletic competence.
These findings are important and require further elabor-
ation. The lower scores on cognitive and motor func-
tioning we found in our study are in line with the
outcomes of diverse neuropsychological studies, in
which was found that children and young adults with
CH scored significantly lower than the norm population
on motor functioning [3,5,6,28-30] and had more pro-
blems with attention and memory [32-36]. So, the
patient’s perception of motor and cognitive functioning,
as measured with the TACQoL, equates with objective
findings. However, worse IQ and motor skills did not ex-
plain the presence of impaired functioning in most other
domains of HRQoL and self-worth, as the results of the
regression analyses demonstrated. So, we can conclude
that patients with CH are at risk for impaired HRQoL
and self-worth, independent of their IQ and motor skills.
Furthermore, no significant association of severity, intial
T4 dose and age at onset of therapy with HRQoL and
self-worth was found.
Therefore, it could assume that living with a chronic
disease as such and/or the negative consequences of CH
despite of its severity, influence functioning in daily life.
CH affects the child’s daily life because of the need of
regular T4-dose adjustments, the daily T4 administra-
tion, frequent T4 and TSH measurements, conscious-
ness of having a chronic disease, and sometimes the
need of adjuvant medical care such as speech training
and physiotherapy. In addition, the cognitive and motor
problems of patients with CH may affect their social life,
self-worth and emotional functioning. From this study
and our previous studies [3,9,37], it is apparent that
patients with CH seem to be vulnerable in these areas.
Besides, one has to keep in mind that a suboptimal thy-
roid hormone state may affect well-being. Whereas the
goal of long-term T4 treatment is to maintain euthyroid-
ism, this remains challenging because of the continuous
need to adapt T4 dose in a growing child and the need
of treatment compliance. It has been shown that differ-
ences in serum FT4 and TSH concentrations, even
within the reference range, may be determinants of psy-
chological well-being in treated hypothyroid patients
[38].
The strength of our study is that we tested a nation-
wide cohort of patients with CH, all treated by pediatri-
cians who followed national guidelines, and that at
psychological assessment, all patients had plasma TSH
concentrations within the reference range. Besides,
HRQoL was assessed by self-report as well as by the par-
ents of the children with CH. Moreover, we tried to
strengthen the clinical meaning of the results, by using
percentages at risk of impaired HRQoL and self-worth
as outcomes, in addition to mean scale scores. This is
considered a suitable way because a golden standard for
bad HRQoL and self-worth is lacking.
The limitations of the current study should also be
taken into account. First, the loss of subjects from the
original cohort restricts the representativeness of the
current sample. However, we clarified the etiology of
both the excluded patients and the patients not willing
to participate (Table 1). Second, we could not use a con-
trol group and no information about the socio- eco-
nomic status of the norm population was available. In
general however, Dutch normative data of standardized
measures such as the CBSK and TACQoL are sufficient
to make adequate comparisons.
Third, caution is called for generalizing our results to
children who are nowadays growing up with CH because
treatment protocols changed since the 1992–1993. The
question is, whether the impaired HRQoL of patients
with CH in our study could be assigned to suboptimal
treatment years ago, as lower initial T4 dose and older
age at onset of therapy compared to the current treat-
ment protocols. In the present we did not found any sig-
nificant association of initial T4 dose and age at onset of
therapy with HRQoL and self-worth, which might be an
indication that the contribution of treatment factors to
psychosocial outcomes in patients with CH is limited.
So, it could be assumed that also children with CH being
treated nowadays should be considered at risk of
impaired HRQoL and self-worth.
Another shortcoming of the study is that we did not
examine other potential risk- and protective factors of
HRQoL and self-worth, as socio-economic and psycho-
social factors (e.g. parenting, family functioning, coping).
Future research should be directed at these factors, in
order to be able to detect and support the children and
adolescents who are at risk for impaired psychosocial
functioning at an early stage. Finally, because of the
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cognitive and motor problems in patients with CH, it
seems important to examine the effect of adjuvant care
like physiotherapy, speech training and intervention pro-
grams directed at the improvement of cognitive
functions.
Conclusion and Clinical implications
This study has shown that children with CH, diagnosed
by neonatal screening, are at increased risk for impaired
quality of life and self worth. In particular, our findings
add to the evidence for motor and cognitive problems in
relation to CH. Following this, we can conclude that
children with CH are vulnerable and that there is need
for specific care. We believe that these results deserve
proper attention and awareness of physicians treating
these children. Furthermore, patients with CH and their
parents should become more aware of the possible nega-
tive consequences of growing up with CH. Follow-up of
patients with CH should not only be a medical/biochem-
ical evaluation but, also to attain the best achievable
quality of life. The focus during the follow-up should
shift to attention to school performances, social-
emotional functioning and supporting the patients.
Therefore routine monitoring HRQoL and social-
emotional functioning in children with CH is recom-
mended. Incorporating patient reported outcomes of
HRQoL in daily clinical practice will contribute to better
communication with health care professionals and
makes it easier for them to refer to the needed care if
necessary [39,40]. In addition, the use of valid and reli-
able screening instruments to detect patients with CH at
risk for social, emotional and behavior problems are
recommended, for example the Strength and Difficulties
Questionnaire (SDQ) [41]. When motor problems are
present, patients should be motivated to engage in sport
activities or should be referred to the physiotherapist if
needed. When cognitive problems are present, psycho-
logical examination would be useful and if necessary,
intervention programs that improve cognitive functions
such as memory and attention functioning or speech
training might thereafter be offered to particular indivi-
duals. Finally, it seems important to stimulate children’s
social performance and to support children with their
social skills.
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